Clinical Trial Update: RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the RLC regimen followed by CR-CHOP in elderly patients with newly diagnosed double-expressor lymphoma. The study status is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Double-expressor Lymphoma | Phase 2 | Status: RECRUITING